Sightera Biosciences
PrivateLast Round
Pre Seed
Jul 17, 2026
Total Funding Raised
$3.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Sightera Biosciences operates in Healthcare & Life Sciences and is based in Niel. Its latest recorded funding round was a Pre Seed round in July 2026.
Sightera Biosciences is a biotechnology company that provides an AI-driven drug discovery platform focused on oncology and regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sightera Biosciences Comparables
Compare Sightera Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InFocus Therapeutics | 80% | |
| Graph Therapeutics | 79% | |
| Orbits Oncology | 78% |
For institutional investors. Book with your work email.
Sightera Biosciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sightera Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Entourage | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2026
Open roles increased from 0 to 1, representing 25% of headcount.
- Jul 17, 2026
$3.4M round led by Entourage, qbic, and Anacura.
For institutional investors. Book with your work email.
Sightera Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sightera Biosciences's valuation, stock price, and market status.
Is Sightera Biosciences a public or private company?
Sightera Biosciences is a private company.
What is the current stock price of Sightera Biosciences?
Sightera Biosciences is a private company, so its shares have no public market price. Caplight tracks Sightera Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sightera Biosciences worth (valuation)?
Valuation information for Sightera Biosciences is not publicly available.
Can I buy Sightera Biosciences stock?
Sightera Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sightera Biosciences's last funding round?
Sightera Biosciences's most recent funding round was Pre Seed on July 17, 2026.
Who are the main investors in Sightera Biosciences?
Key investors in Sightera Biosciences include Entourage.
Will Sightera Biosciences IPO soon?
No public IPO plans have been announced for Sightera Biosciences.
How can I track Sightera Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Sightera Biosciences's shares on secondary markets.